Millions of Americans have been diagnosed with type 2 diabetes. As the treatment of diabetes has become increasingly sophisticated, management requires a multidisciplinary team approach. Ongoing oversight and follow-up is critical to make medication adjustments that can slow or prevent disease progression and reduce the risk of cardiovascular disease and death. Oral medications such as metformin, thiazolidinediones and sulfonylureas are available for some patients. A new class of medications called DPP-4 inhibitors (Januvia, Onglyza) help improve A1C without causing hypoglycemia. As the disease progresses, oral combination medications such as Janumet, Kombiglyze can help. Depending on disease severity, insulin may also be required.

Medivo’s unique ability to monitor millions of daily lab test offers a valuable addition to the multidisciplinary team. By identifying diabetic patients who are not well controlled and alerting them and their physicians to their increased risk, Medivo provides a vital tool for optimum disease management and patient education.